Active ingredientAtglistatinCat. No. P-A206-001CAS 1469924-27-3Family · Pharmaceutical analytical standards
Atglistatin
A small molecule that selectively inhibits adipose triglyceride lipase (ATGL), the enzyme that starts the release of fatty acids from fat stores; described in 2013 by researchers in Graz, Austria, it is used as a research tool in metabolism. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?It blocks the mouse enzyme well but not the human one: in 2022 the same Graz group found that just three amino acids decide which species an inhibitor works on, and created one for the human enzyme.
Go to the active ingredient →Active ingredientAtglistatinCat. No. P-A206-001CAS 1469924-27-3
NitrosamineN-Nitroso AtglistatinCat. No. P-A206-002
NitrosamineN1-Nitroso-N1-Desmethyl AtglistatinCat. No. P-A206-003
NitrosamineN2-Nitroso N2-Desmethyl AtglistatinCat. No. P-A206-004
ImpurityDinitro N1-Desmethyl AtglistatinCat. No. P-A206-005
ImpurityDinitro N2-Desmethyl AtglistatinCat. No. P-A206-006
ImpurityN1-Desmethyl AtglistatinCat. No. P-A206-007
ImpurityN2-Desmethyl AtglistatinCat. No. P-A206-008No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.